What is the price target for ACET stock?
13 analysts have analysed ACET and the average price target is 54.06 USD. This implies a price increase of 673.39% is expected in the next year compared to the current price of 6.99.
ADICET BIO INC (ACET) Forecast, Price Target & Analyst Ratings
NASDAQ:ACET • US0070022076
Current stock price
6.99 USD
+0.11 (+1.6%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ADICET BIO INC (ACET).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 4, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$3.14
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$54.06
Upside
+ 673.39%
From current price of $6.99 to mean target of $54.06, Based on 13 analyst forecasts
Low
$18.18
Median
$26.52
High
$134.40
Price Target Revisions
1 Month
-13.82%
3 Months
597.37%
Price Target Summary
13 Wall Street analysts provided a forecast for the next 12 months for ACET. The average price target is 54.06 USD. This implies a price increase of 673.39% is expected in the next year compared to the current price of 6.99.
The average price target has been revised upward by 597.37% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
86.15%
ACET was analyzed by 13 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about ACET.
In the previous month the buy percentage consensus was at a similar level.
ACET was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-23 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-03-13 | Guggenheim | Maintains | Buy -> Buy |
| 2026-01-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-01-06 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-11-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-08 | Guggenheim | Maintains | Buy -> Buy |
| 2025-09-19 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-03-21 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-03-07 | Citizens Capital Markets | Reiterate | Market Perform -> Market Perform |
| 2025-03-07 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-02-27 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-02-06 | JMP Securities | Reiterate | Market Perform -> Market Perform |
| 2025-02-05 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-12-19 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-18 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-10-16 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-09-30 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-09-20 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-09-19 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-09-11 | Jones Trading | Maintains | Buy -> Buy |
| 2024-09-11 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-09-11 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-08-14 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 4, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$3.14
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- 36.66%
- Number of Analysts
- 7
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-4.85%
EPS (3 Months)
-1,604.01%
Next Earnings Summary
ACET is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -3.14 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates 2026 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 17.9M | 9.73M -45.64% | 24.99M 156.83% | 637.5K -100.00% | 93.98M | 226.07M 140.55% | 203.6M -9.94% | 373.4M 83.40% | 553.66M 48.28% | ||||||
| EBITDA YoY % growth | -37.96M 55.51% | -58.69M -54.61% | -69.97M -19.22% | -159.12M -80.76% | -156.06M 3.91% | -176.46M -45.20% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -39.19M 54.14% | -60.23M -53.69% | -72.55M -20.45% | -153.056M -82.74% | -133.443M 3.45% | -119.268M 6.82% | -128.686M -7.90% | -135.485M -5.28% | -147.63M -8.96% | -61.363M 58.43% | 32.499M 152.96% | -10.254M -131.55% | 127.47M 1,343.12% | 273.45M 114.52% | |
| Operating Margin | -218.94% | -619.01% | -290.32% | -24,008.71% | N/A | N/A | N/A | N/A | N/A | -65.29% | 14.38% | -5.04% | 34.14% | 49.39% | |
| EPS YoY % growth | -90.88 65.62% | -33.12 63.56% | -27.36 17.39% | -54.16 -94.15% | -22.53 59.64% | -16.65 16.14% | -11.23 37.53% | -10.13 9.82% | -10.08 0.48% | 1.39 113.83% | 10.18 630.23% | -11.59 -213.83% | -3.43 70.42% | 5.22 252.38% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -3.14 36.66% | -2.59 52.38% | -2.38 48.69% | -2.21 24.92% |
| Revenue Q2Q % growth | ||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -30.69M -2.70% | -33.935M -4.76% | -35.423M -26.73% | -36.435M -14.27% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
12.91%
EPS Next 5 Year
20.74%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
ADICET BIO INC / ACET Forecast FAQ
Can you provide the upcoming earnings date for ADICET BIO INC?
ADICET BIO INC (ACET) will report earnings on 2026-05-04.
What are the consensus estimates for ACET stock next earnings?
The consensus EPS estimate for the next earnings of ADICET BIO INC (ACET) is -3.14 USD and the consensus revenue estimate is 0 USD.
How many analysts cover ADICET BIO INC (ACET) stock?
The number of analysts covering ADICET BIO INC (ACET) is 13.